The Ministry of Health and Prevention, represented by the Public Health Policy and Licensing Field and the Drug Division, organized at the Raffles Hotel in Dubai the 6th National Seminar of Continuum of Pharmacovigilance and Medication Safety in the UAE being held under the patronage of H.E. Abdulrahman bin Mohammed Al Owais, Minister of Health and Avoidance and in cooperation with the Pharmaceutical Study and Manufacturers Organization.

H.E. Dr. Amin Hussein Al Amiri, Assistant Undersecretary for Public Health Policy and Licenses and Chairman of the Greater Board for Pharmacovigilance, noted the climbing global recognition of pharmacovigilance taking into account the expanding security worries influencing the health sector such as self-medication practices globalization, consumerism, and the growth in free trade and interaction throughout borders. Various other issues include unlawful medicine sale online, substance abuse, prevalent manufacture and sale of fake and ineffective medicines globally, boosting use typical and herbal medicines with potential unfavorable effect.

Global facts about adverse drug reactions (ADRs)

H.E. said that negative medication responses (ADRs) are among the top 10 causes of fatality around the world, with a roughly 5 per cent of individuals are hospitalized due to ADRs and 6 to 10 per cent of in-patients will experience a severe case of ADRs during a hospital stay. ADR-related prices may increase to USD 136 billion each year as per a report titled 'FDA: Preventable Adverse Medication Responses: A Concentrate on Drug Reactions 2016.' The increasing expenses are attributed to extended healthcare facility keep, extra clinical investigations. The good news is that regarding 50 per cent of ADRS could be prevented.

Ministry: Continuous enactment of regulations and legislations

H.E. Dr. Al Amiri reaffirmed the UAE's eagerness to develop guidelines and pass regulations according to international ideal methods. He mentioned Ministerial Mandate 60-2013 controling clinical shops; Mandate No. 71 for 2013 allowing local producers of pharmaceutical products and common medicine firms to apply for patents for innovative medicines within 24 months; Ministerial Decree No. 1122 of 2014 or the 'Narcotics, Controlled- and Semi-Controlled Medicines- Classification, Suggesting, and Dispense' which was later on modified by Ministerial Decree No. 888 of 2016; Closet Choice No 44-2016 managing the UAE Ministry of Health and Avoidance's services fee; Ministerial Mandate 1110-2016 regarding scientific offices; and Round No. 298 for 2016 pertaining to On scientific offices.

Pharmacovigilance: Major Goals

H.E. Dr. Al Amiri said that the major goals of pharmacovigilance are very early discovery of unknown security problems; decision of regularity of use; recognition of threat factors; quantifying risks; risk prevention among patients; and logical and secure use of medications. Ministrys role enhancing pharmacovigilance through Drug Department

H.E. Dr. Al Amiri claimed that the Drug Departmen advertises pharmacovigilance by regulating and licensing medicines and pharmaceutical products in the UAE in coordination with health authorities and local universities; managing the importation and distribution of all pharmaceutical products; evaluating and conducting high quality assessment of pharmaceutical products; and evaluating and monitoring of pharmaceutical products. The Division likewise recalls medications and problems signals relating to security, efficiency, and top quality of medicines in the UAE, along with screens records on ADRs and advisories from worldwide medicine regulatory authorities and GCC health bodies. It also conducts post-marketing monitoring to make sure conformity and screen any sub-standard, faulty or counterfeit materials in the UAE market.

Role of National Committee for Pharmacovigilance

The responsibilities of the National Committee for Pharmacovigilance include giving technological support and related clinical tasks; prolonging counseling and medication security details; analyzing medications and their side effects together with the Medication Control Department and local health authorities; sharing information regarding adverse effects in local communities.

The adoption of a standard kind of documentation on drug adverse effects at the nation level, recognition raising and promotion of the relevance of medicine caution, and the continued should support tasks targeted at health-care workers and community members. Standardization of procedures controling drug watchfulness, coordination with the National Center for Drugs and Toxics, and strengthening participation and control between local and international drug authorities.